References
- Rotoli B., De Renzo A., Frigeri F., Buffardi S. Treatment of Waldenstrom's macroglobulinemia. Forum 1991; 2: 94–102
- McCallister B. D., Bayrd E. D., Herrison E. G., Jr., McGuckin W. F. Primary macroglobulinemia: Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am. J. Med. 1967; 43: 394–434
- MacKenzie M. R., Fudenberg H. H. Macroglobulinemia: An analysis of forty patients. Blood 1972; 39: 874–889
- Krajny M., Pruzanski W. Waldenstrom's macroglobulinemia: Review of 45 cases. Can. Med. Assoc. J. 1976; 114: 899–905
- Golomb H. M., Fefer A., Golde D. W., Ozer H., Port-Lock C, Silber R., Rappeport J., Ratain M. J., Thompson J., Bonnem E. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with inter-feron-a 2b. Semin. Oncol. 1988; 15(Suppl. 5)7–9
- Talpaz M., Kantarjian H. M., McCredie K. B., Keating M. J., Trujillo J., Gutterman J. Clinical investigation of human a interferon in chronic myelogenous leukemia. Blood 1987; 69: 1280–1288
- Ohno R. Interferons in the treatment of multiple myeloma. Int. J. Cancer 1987; (Suppl. 1): 14–20
- Gilewski T. A., Richards J. M. Biologic response modifiers in non-Hodgkin's lymphomas. Semin. Oncol. 1990; 17: 74–87
- Montserrat E., Villamore N., Urbano-Ispizua A., Ribera J. M., Rozman C. a interferon in chronic lymphocytic leukaemia. Eur. J. Cancer 1991; 27(Suppl. 4)S74–S77
- Whicher J. T., Calvin J., Riches P., Warren C. The laboratory investigation of paraproteinaemia. Ann. Clin. Biochem. 1987; 24: 119–132
- Efron B. The efficiency of logistic regression compared to normal discriminant analysis. J. Amer. Statist. Assoc 1975; 70: 892–898
- Gill J. S., Beevers D. G., Zezulka A. V., Davies P. Relation between initial blood pressure and its fall with treatment. Lancet 1985; 567–569
- De Rosa G., De Renzo A., Buffardi S., Rotoli B. Treatment of Waldenstrom's macroglobulinemia with interferon. Haematologica 1989; 74: 313–315
- Carella A. M. a-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenstrom's macroglobulinemia. Haematologica 1990; 75: 581
- Quesada J. R., Alexanian R., Kurzrock R, Barlogie B., Saks S., Gutterman J. U. Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia. Am. J. Hematol. 1988; 29: 1–4
- Patriarca F., Russo D., Gallizia C., De Savorgnani M. N., Fantini O., Guaran A., Messina Q., Monco M. A., Na-Liato P, Pecorari P., Polacco A., Radin E., Rorai E., Saladin F., Scaramella G., Baccarani M. Interferon alfa nelle sindromi linfoproliferative a piccola massa: leucemia linfatica cronica, mieloma multiplo e macroglobulinemia di Waldenstrom. Proceedings of the 33rd Congress of the Italian Society of Hematology. Verona 1991; 38
- Isa L., Scapaticci R., Moriglioni M. Terapia della macroglobulinemia di Waldenstrom. Inefficacia dell'interferon. Proceedings of the 33rd Congress of the Italian Society of Hematology. Verona 1991; 128
- Quesada J. R., Talpaz M., Rios A., Kurzrock R., Gutterman J. U. Clinical toxicity of interferons in cancer patients: a review. J. Clin. Oncol. 1986; 4: 234–243
- Ballester O. F., Spiers A. S. D., Grattan J. Autoimmune hemolytic anemia (AIHA) accompanying treatment with a interferon in a patient with chronic granulocytic leukemia. Blood 1989; 74(Suppl. 1)352
- Rabinowitz A. P., Hu E., Watkins K., Mazumder A. Hemolytic anemia in a cancer patient treated with recombinant interferon gamma. J. Biol. Response Mod. 1990; 9: 256–259
- Andriani A., Bibas M., Cavallaro A., De Renzo A., Mar-Cenb R., Rotoli B. Autoimmune hemolytic anemia during treatment with a interferon in five patients with hematological diseases. Haematologica 1991; 76(Suppl. 4)605a
- Dimopulos M. A., Keating M. J., Alexanian R. Macroglobulinemia: at last a new treatment. Proceedings of Leukemia: The next questions, Houston, Texas, 1993, abstract book.
- Keating M. J. Immunosuppression with purine analogues. The flip side of the gold coin. Ann. Oncol. 1993; 41: 347–348